Sign Out
Prevention of atherosclerotic events in patients with history of recent myocardial infarction (MI) (within a few days until <35 days from occurrence), recent ischemic stroke (from 7 days until <6 months) or established peripheral arterial disease.
Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q wave MI) including patients who are managed medically with percutaneous coronary intervention (with or without stent) or coronary artery bypass graft (CABG).
It is given prophylactically as an alternative to aspirin in patient at risk of thromboembolic disorders eg, MI, peripheral arterial disease and stroke.
Continue with Google